Stem-cell hierarchy in skin cancer

Nature Reviews Cancer

Volumn 3, Issue 6, 2003, Pages 434-443

  Perez Losada, Jesus ^a   Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL INTERACTION; CYTOARCHITECTURE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; SKIN CANCER; STEM CELL; STROMA CELL; TARGET CELL; TISSUE INJURY; TUMOR RECURRENCE; ANIMAL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION; PATHOLOGY; SKIN TUMOR;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; SKIN NEOPLASMS; TUMOR STEM CELLS;

EID: 0038819885     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1095     Document Type: Review

References (101)

1. Donjacour, A. A. & Cunha, G. R. Stromal regulation of epithelial function. Cancer Treat Res. 53, 335-364 (1991).
2. Paus, R., Peters, E. M., Eichmuller, S. & Botchkarev V. A. Neural mechanisms of hair growth control. J. Invest. Dermatol. Symp. Proc. 2, 61-68 (1997).
3. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 7, 57-70 (2000).
4. Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146 (1999). An important demonstration of the crucial role of the stromal environment in the malignant transformation of cancer cells.
5. Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56 (2001). Provides evidence that humoral factors produced at distant sites can influence metastatic dissemination of tumour cells.
6. Szabowski, A. et al. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103, 745-755 (2000).
7. Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011 (1999).
8. Kurose, K. et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet. 32, 355-357 (2002).
9. Sell, S. & Pierce, G. B. Maturation arrest of stem cell differation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 70, 6-22 (1994).
10. Yuspa, S. H. et al. Regulation of hair follicle development: an in vitro model for hair follicle invasion of dermis and associated connective tissue remodeling. J Invest. Dermatol. 101 (Suppl. 1), 27S-32S (1993).
11. Gilbert, C. W. & Laitha, L. G. in Cellular Radiation Biology 118-154 (Williams and Wilkins, Baltimore, Maryland, USA, 1965).
12. Mackenzie, I. C. Relationship between mitosis and the ordered structure of the stratum corneum in mouse epidermis. Nature 226, 653-655 (1970).
13. Hume, W. J. Keratinocyte proliferative hierarchies confer protective mechanisms in surface epithelia. Br. J. Dermatol. 112, 493-502 (1985).
14. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
15. Spradling, A., Drummond-Barbosa, D. & Kai, T. Stem cells find their niche. Nature 414, 98-104 (2001).
16. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
17. Hamburger, A. W. & Salmon, S. E. Primary bioassay of human tumor stem cells. Science 197, 461-463 (1977).
18. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997).
19. Cobaleda, C. et al. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 95, 1007-1013 (2000).
20. Al'Hajj, M. et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
21. Park, C. H., Bergsagel, D. E. & McCulloch, E. A. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl Cancer Inst. 46, 411-422 (1971).
22. Greaves, M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 234, 697-704 (1986).
23. Fuchs, E. & Raghavan, S. Getting under the skin of epidermal morphogenesis. Nature Rev. Genet. 3, 199-209 (2002).
24. Niemann, C. & Watt, F. M. Designer skin: lineage commitment in postnatal epidermis. Trends Cell Biol. 12, 185-192 (2002).
25. Potten, C. S. & Booth, C. Keratinocyte stem cells: a commentary. J. Invest. Dermatol. 119, 888-899 (2002).
26. Kamimura, J., Lee, D., Baden, H. P., Brissette, J. & Dotto, G. P. Primary mouse keratinocyte cultures contain hair follicle progenitor cells with multiple differentiation potential. J. Invest. Dermatol. 109, 534-540 (1997).
27. Ghazizadeh, S. & Taichman, L. B. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J. 20, 1215-1222 (2001).
28. Cotsarelis, G., Sun, T. T. & Lavker, R. M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 329-337 (1990).
29. Taylor, G., Lehrer, M. S., Jensen, P. J., Sun, T. T. & Lavker, R. M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102, 451-461 (2000).
30. Rochat, A., Kobayashi, K. & Barrandon, Y. Location of stem cells of human hair follicles by clonal analysis. Cell 76, 1063-1073 (1994).
31. Potten, C. S. Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int. Rev. Cytol. 69, 271-318 (1981).
32. Klein-Szanto, A. J., Ruggeri, B., Bianchi, A. & Conti, C. J. Cellular and molecular changes during mouse skin tumor progression. Recent Results Cancer Res. 128, 193-204 (1993).
33. Frame, S. & Balmain, A. Integration of positive and negative growth signals during Ras pathway activation in vivo. Curr. Opin. Genet. Dev. 10, 106-113 (2000).
34. Hunter, J. A., Savin J. A. & Dahl MV. Clinical Dermatology (Blackwell Science, Oxford, 1995).
35. Barrandon, Y., Morgan, J. R., Mulligan, R. C. & Green, H. Restoration of growth potential in paraclones of human keratinocytes by a viral oncogene. Proc. Natl Acad. Sci. USA 86, 4102-4106 (1989).
36. Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell. 3, 565-577 (1999).
37. Bailleul, B. et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62, 697-708 (1990). See reference 39.
38. Greenhalgh, D. A. et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog. 7, 99-110 (1993).
39. Brown, K., Strathdee, D., Bryson, S., Lambie, W. & Balmain, A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol. 8, 516-524 (1998). This article (together with reference 37) shows that benign tumours that are at risk of malignant conversion are primarily derived from cells located within the hair follicle, whereas papillomas with very low malignant potential can arise from the interfollicular or suprabasal cells. Together, these papers show that the nature of the cell in which tumour initiation occurs is one of the main determinants of malignant potential.
40. Wang, X. J., Liefer, K. M., Greenhalgh, D. A. & Roop, D. R. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation. Mol. Carcinog. 26, 305-311 (1999).
41. Cairns, J, Mutation selection and the natural history of cancer. Nature 255, 197-200 (1975).
42. Cairns, J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl Acad. Sci. USA 99, 10567-10570 (2002).
43. Balmain, A., Ramsden, M., Bowden, G. T. & Smith, J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307, 658-660 (1984).
44. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
45. Hennings, H., Shores, R., Mitchell, P., Spangler, E. F. & Yuspa, S. H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6, 1607-1610 (1985).
46. Tennenbaum, T. et al. The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis Cancer Res. 53, 4803-4810 (1993).
47. Cano, A. et al. Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha-6 beta-4 intergdns is altered in pre-malignant skin tumors of p53-deficient mice. Int. J. Cancer 65, 254-262 (1996).
48. Argyns, T. S. Promotion of epidermal carcinogenesis by repeated damage to mouse skin. Am. J. Ind. Med. 8, 329-337 (1985).
49. Morris, R. J., Tryson, K. A. & Wu, K. Q. Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles. Cancer Res. 15, 226-229 (2000).
50. Reynolds, A. J. & Jahoda, C. A. Cultured dermal papilla cells induce follicle formation and hair growth by transdifferentiation of an adult epidermis. Development 115, 587-593 (1992).
51. Bachoo, R. M. et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269-277 (2002).
52. Levy, L., Broad, S., Diekmann, D., Evans, R. D. & Watt, F. M. Betal integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol. Biol. Cell. 11, 453-466 (2000).
53. Li, A., Simmons, P. J. & Kaur, P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc. Natl Acad. Sci. USA 95, 3902-3907 (1998).
54. Tani, H., Morris, R. J. & Kaur, P. Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc. Natl Acad. Sci. USA 97,10960-10965 (2000).
55. Van Duuren, B. L., Sivak, A., Katz, C., Seidman, I. & Melchionne, S. The effect of ageing and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res. 35, 502-505 (1975). Classic work in which the authors showed that the initiating effect of the carcinogen persists even when the interval between initiation and promotion is more than 1 year.
56. Jonason, A. S. et al. Frequent clones of p53-mutated keratinocytes in normal human skin Proc. Natl Acad. Sci USA 93, 14025-14029 (1996).
57. Rehman, I. et al. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N′-nitro-N-nitrosoguanidine and promoted by mezerein. Mol. Carcinog. 27, 298-307 (2000).
58. Megosh, L., Halpern, M., Farkash, E. & O'Brien, T. G. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice. Mol. Carcinog. 22, 145-149 (1998).
59. Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A. & Schwarz, M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 20, 7812-7816 (2001).
60. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
61. Yamasaki, H. et al. Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation. Carcinogenesis 6, 1173-1179 (1985).
62. Mackenzie, I. C. & Bickenbach, J. R. Label-retaining keratinocytes and Langerhans cells in mouse epithelia. Cell Tissue Res. 242, 551-556 (1985).
63. Gat, U., DasGupta, R., Degenstein, L. & Fuchs, E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95, 605-614 (1998). Shows that the expression of β-catenin in the basal layer induces hair-follicle formation and specific hair tumours. Conversely, deletion of β-catenin (reference 74) in the basal layer induces the targeted cells to adopt an epidermal cell fate.
64. Niemann, C., Owens, D. M., Hulsken, J., Birchmeier, W. & Watt, F. M Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129, 95-109 (2002).
65. Merrill, B. J., Gat, U., DasGupta, R. & Fuchs, E. Tof3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 15, 1688-1705 (2001).
66. Grachtchouk, M. et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nature Genet. 24, 218-217 (2000).
67. Nilsson, M. et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl Acad. Sci. USA 97, 3438-3443 (2000).
68. van Hogedinden, M., Rozell, B. L., Ahdund-Richter, L. & Toftgard, R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59, 3299-3303 (1999).
69. Seitz, C. S., Lin, Q., Deng, H. & Khavari, P. A. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc. Natl Acad. Sci. USA 95, 2307-2312 (1998).
70. Dajee, M, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639-643 (2003).
71. Toftgard, R. Hedgehog signalling in cancer. Cell. Mol. Life Sci. 57, 1720-1731 (2000).
72. Bonifas, J. M. et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J. Invest. Dermatol. 116, 739-742 (2001).
73. Chan, E. F., Gat, U., McNiff, J. M. & Fuchs, E. A common human skin tumour is caused by activating mutations in beta-catenin. Nature Genet. 21, 410-413 (1999).
74. Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. & Birchmeier, W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105, 533-545 (2001). See reference 63.
75. Vassar, R., Rosenberg, M., Ross, S., Tyner, A. & Fuchs, E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl Acad. Sci USA 86, 1563-1567 (1989).
76. Byrne, C. & Fuchs, E. Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol. Cell. Biol. 13, 3176-3190 (1993).
77. Lavker, R. M. & Sun, T. T. Epidermal stem cells: properties, markers, and location. Proc. Natl Acad. Sci. USA 97, 13473-13475 (2000).
78. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
79. Potten, C. S. The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet. 7, 77-88 (1974).
80. Furstenberger, G., Gross, M., Schweizer, J., Vogt, I. & Marks, F. Isolation, characterization and in vitro cultivation of subfractions of neonatal mouse keratinocytes: effects of phorbol esters. Carcinogenesis 7, 1745-1753 (1986).
81. Yuspa, S. H., Ben, T., Hennings, H. & Lichti, U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 42, 2344-2349 (1982).
82. Parkinson, E. K., Grabham, P. & Emmerson, A. A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation. Carcinogenesis 4, 857-861 (1983).
83. Morris, R. J., Fischer, S. M. & Slaga, T. J. Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J. Invest. Dermatol. 84, 277-281 (1985).
84. Gandarillas, A. & Watt, F. M. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 11, 2869-2882 (1997).
85. Waikel, R. L., Kawachi, Y., Waikel, P. A., Wang, X. J. & Roop, D. R. Deregulated expression of c-Myc depletes epidermal stem cells. Nature Genet. 28, 165-168 (2001). Shows that constitutive expression of c-Myc in basal epidermal cells causes depletion of the stem-cell pool, indicating a role for c-Myc as a regulator of epidermal stem-cell maintenance. See also reference 86.
86. Arnold, I. & Watt, F. M. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr. Biol. 11, 558-568 (2001). See reference 85.
87. Frye, M., Gardner, C., Li, E. R., Arnold, I. & Watt, F. M. Evidence that c-Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793-2808 (2003).
88. Fidler, I. J. The biology of human cancer metastasis. 7th Jan Waldenstrom Lecture. Acta Oncol. 30, 668-675 (1991).
89. Blau, H. M., Brazelton, T. R. & Weimann, J. M. The evolving concept of a stem cell: entity or function? Cell 105, 829-841 (2001).
90. Gimbrone, M. A. Jr, Cotran, R. S., Leapman, S. B. & Folkman, J. Tumor growth and neovasculanzation: an experimental model using the rabbit cornea. J. Natl Cancer Inst. 52, 413-427 (1974).
91. Naumov, G. N., MacDonald, I. C., Chambers, A. F. & Groom, A. C. Solitary cancer cells as a possible source of tumour dormancy? Semin. Cancer Biol. 11, 271-276 (2001).
92. Hotyoake, T. L. et al. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. Blood 97, 720-728 (2001).
93. van Rhee, F. et al. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant, 14, 609-612 (1994).
94. Yong, A. S. & Goldman, J. M. Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation. Bone Marrow Transplant. 23, 827-828 (1999).
95. Woodruff, M. Interaction of cancer and host (the Walter Hubert Lecture, 1982). Br. J. Cancer 46, 313-322 (1982).
96. Callaway, M. P. & Briggs, J. C. The incidence of later recurrence (greater than 10 years): an analysis of 536 consecutive cases of cutaneous melanoma. Br. J. Plast. Surg. 42, 46-49 (1989).
97. van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Eng. J. Med. 347, 1999-2009 (2002).
98. Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors Nature Genet. 33, 49-54 (2003).
99. Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002).
100. Bruserud, O. & Gjertsen, B. T. New strategies for the treatment of acute myelogenous leukemia: differentiation induction - present use and future possibilities. Stem Cells 18, 57-65 (2000).
101. Demetri, G. D. et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand in patients with liposarcoma. Proc. Natl Acad. Sci. USA 96, 3951-3956 (1999).